Mangoceuticals, Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $80.00K, a 97.48% decline year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $589.11K, a 69.61% decline year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $5.54M, a 1108.01% increase year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $3.18M, a 292.88% increase year-over-year.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for fiscal 2025 was $10.72M, a 408.80% increase from fiscal 2024.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for fiscal 2024 was $2.11M, a 37.61% increase from fiscal 2023.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for fiscal 2023 was $1.53M, a 183.42% increase from fiscal 2022.
- Mangoceuticals, Inc. stock issued during period, value, issued for services for fiscal 2022 was $540.07K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $80.00K 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $589.11K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $10.72M 10-K · filed 2026-04-01 | |
| 2025-09-30 | $5.54M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $3.18M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $1.94M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $2.11M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $458.86K 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $808.15K 10-Q/A · filed 2025-11-14 | |
| 2024-03-31 | $416.50K 10-Q/A · filed 2025-11-14 | |
| 2023-12-31 | $1.53M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $84.75K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $387.00K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $700.00K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $540.07K 10-K · filed 2024-04-01 | |
| 2022-09-30 | $265.00K 10-Q · filed 2023-10-27 | |
| 2022-06-30 | $225.00K 10-Q · filed 2023-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |